Biopharmaceutical developer and manufacturer PnuVax creates vaccines for communities around the world. PnuVax vaccines help reduce antibiotic resistance and other common problems associated with vaccinations.

1. SEVERE VACCINE ALLERGIES ARE
EXTREMELY RARE
PnuVax

2. INTRODUCTION
• Biopharmaceutical developer and manufacturer PnuVax creates vaccines for
communities around the world. PnuVax vaccines help reduce antibiotic
resistance and other common problems associated with vaccinations.
According to the World Health Organization (WHO), one of the top-10
global health threats in 2019 is vaccine hesitancy. This hesitancy stems from
patients' concern for safety, health, and other vaccine effects, such as
allergic reactions.
However, allergies to vaccinations are exceedingly rare. Studies by the
United States Centers for Disease Control and Prevention have found that
33 patients out of 25 million have had a serious, life-threatening allergic
reaction to a vaccine.
It is believed that patients may have a vaccine allergy if they are allergic to
eggs or gelatin products. Gelatin is found in several common vaccines,
including measles, influenza, and rabies. Egg protein is contained in
vaccines for mumps and yellow fever.